Please select the option that best describes you:
Do you treat adenocarcinoma in situ (AIS) or minimally invasive adenocarcinoma (MIA) of the lung with SBRT in medically inoperable patients?
Given the lepidic growth pattern, do you use similar margins as with frankly invasive lung tumors? Are there any challenges localizing the target with daily CBCT due to the often ground glass appearance?
Answer from: Radiation Oncologist at Academic Institution
The literature on this for SBRT is quite thin. We looked at our institutional experience a few years ago using SBRT for MIA/AIS. You'll have to excuse the onerous title. It was published right around when we started switching away from the term BAC, and we wanted to make sure folks could find it...
Sign in or Register to read more